IL2 and rheumatoid arthritis: Therefore, in patients with RA, whether serum IL-2 levels are related to disease activity, whether they affect the development and differentiation of lymphocyte subsets and the potential therapeutic prospect of low-dose IL-2 in RA are clinical frontier hotspots.